Because of the marked increase in the prevalence of both liver cancer and diabetes27, 28, 29, it is important to understand the molecular basis governing the functional interplay of these two diseases, as well as the potential role of YAP and O-GlcNAcylation in these diseases. This evidence concerns the gene YAP1 and liver cancer.